Partial Priapism Treated with Pentoxifylline

Int Braz J Urol. 2015 Jul-Aug;41(4):804-7. doi: 10.1590/S1677-5538.IBJU.2014.0363.

Abstract

A 26-year-old man suffering from partial priapism was successfully treated with a regimen including pentoxifylline, a nonspecific phosphodiesterase inhibitor that is often used to conservatively treat Peyronie's disease. CASE HYPOTHESIS: Partial priapism is an extremely rare urological condition that is characterized by thrombosis within the proximal segment of a single corpus cavernosum. There have only been 36 reported cases to date. Although several factors have been associated with this unusual disorder, such as trauma or bicycle riding, the etiology is still not completely understood. Treatment is usually conservative and consists of a non-steroidal anti-inflammatory and anti-thrombotic. Promising future implications: This case report supports the utilization of pentoxifylline in patients with partial priapism due to its anti-fibrogenic and anti-thrombotic properties.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Dysuria / etiology
  • Humans
  • Male
  • Penile Induration / drug therapy
  • Pentoxifylline / therapeutic use*
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Priapism / diagnostic imaging
  • Priapism / drug therapy*
  • Priapism / etiology
  • Thrombosis / complications
  • Thrombosis / etiology
  • Tomography, X-Ray Computed

Substances

  • Phosphodiesterase Inhibitors
  • Pentoxifylline